Fedwatch: How Few i...
Health Care: Drugs
Array BioPharma Inc. (ARRY: NASDAQ)
$4.96 -0.13 | -2.55%
06/18/13 - 04:00 PM ET
Company Cash Flow
| Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -23.58M | -56.32M | -77.63M | -127.82M |
| Operating Gains/Losses | 942.00K | 4.45M | -1.30M | -11.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 2.01M | -585.00K | -1.06M | 1.82M |
| (Decrease) Increase In Other Current Liabilities | 5.79M | 372.00K | 4.72M | -6.98M |
| (Increase) Decrease In Other Working Capital | -34.94M | -30.05M | 75.04M | 839.00K |
| Other Non-Cash Items | 8.96M | 9.70M | 12.11M | 31.77M |
| Net Cash From Continuing Operations | -33.55M | -65.94M | 17.56M | -92.94M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -33.55M | -65.94M | 17.56M | -92.94M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 34.06M | 129.01M | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.44M | -1.90M | -1.25M | -2.94M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -51.34M | -53.04M | -78.78M | -19.14M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -18.72M | 74.07M | -69.06M | 29.00M |
| Issuance of Debt | 0.00 | 0.00 | 40.00M | 40.00M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 68.31M | 7.55M | 12.77M | 1.69M |
| Repayment of Long-Term Debt | -4.35M | -150.00K | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -4.00M | -281.00K | -1.62M | -1.00M |
| Net Cash From Financing Activities | 59.97M | 7.12M | 51.15M | 40.69M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 7.70M | 15.25M | -356.00K | -23.25M |
Portfolios with ARRY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
Latest ARRY Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.02.13 | 02:04 pm
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- The Twitterverse's Biotech Stock Picks for 2013 01.02.13 | 08:01 am
- 4 Biotech Stocks Under $10 Moving Higher 11.27.12 | 02:11 pm
- Stocks Finish Tough Week With Slight Gains 11.09.12 | 05:11 pm
- 4 Biotech Stocks Under $10 Soaring Higher 09.25.12 | 02:09 pm
- Stocks Under $10: Blossoming Biotech Play
09.25.12 | 06:09 am - 3 Stocks Under $10 Moving Higher 09.20.12 | 02:09 pm
- Array BioPharma's CEO Presents At Morgan Stanley Healthcare Conference - Transcript 09.10.12 | 04:09 pm
- Array BioPharma's CEO Discusses F4Q2012 Results - Earnings Call Transcript 08.14.12 | 04:08 pm
Press Releases for ARRY
- Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2013 On May 6, 2013 - PR Newswire 04.29.13 | 01:04 pm
- Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting - PR Newswire 12.10.12 | 04:12 pm
- Array BioPharma Announces Pricing Of Public Offering Of Common Stock - PR Newswire 11.09.12 | 08:11 am
- Array BioPharma To Present At The UBS Global Life Sciences Conference - Business Wire 09.11.12 | 05:09 pm
- Array BioPharma Announces Changes To Board Of Directors - Business Wire 08.31.12 | 04:08 pm
- Array BioPharma To Present At The Stifel Nicolaus Healthcare, NewsMakers In The Biotech Industry And Morgan Stanley Global Healthcare Conferences - Business Wire 08.29.12 | 04:08 pm
- Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2012 - Business Wire 08.13.12 | 04:08 pm
- Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2012 On August 13, 2012 - Business Wire 08.06.12 | 05:08 pm
- Array BioPharma’s ARRY-797 Meets Primary Endpoint In Clinical Proof Of Concept Trial In Osteoarthritis Patients Whose Pain Is Poorly Controlled By NSAIDs - Business Wire 07.31.12 | 04:07 pm
- Andrew Robbins, Senior Vice President, Commercial Operations, Array BioPharma (Photo: Business Wire) - Business Wire 07.24.12 | 01:07 pm
Partner Headlines for ARRY
- Array Announces Changes to Board - Benzinga 08.31.12 | 04:08 pm
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.15.12 | 09:08 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 08.13.12 | 09:08 am
- After-Hours Earnings Report for August 13, 2012 : IOC, IAG, WX, ARRY, ANW, LPR, FRF, TSPT, PDII, AMID, FENG, SUMR - NASDAQ 08.13.12 | 04:08 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 08.03.12 | 09:08 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.01.12 | 09:08 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 07.26.12 | 09:07 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 07.20.12 | 09:07 am
- Amarin Review PUBLISHED Inadvertently and 4 Stocks that Have Soared to 52-Week Highs - Wall St. Cheat Sheet 07.19.12 | 09:07 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 07.17.12 | 09:07 am
